Real-world Clinical Outcomes of the MITRIS RESILIA Mitral Valve

计划入组 504 人 · 首次发布于 2022 年 9 月 2 日

MITRIS China Post Market Clinical Follow-up (PMCF) Study

计划入组 250 人 · 首次发布于 2025 年 7 月 11 日

Clinical Outcomes of Edwards Lifesciences MITRIS RESLILA Mitral Valve in the Asian Population

计划入组 200 人 · 首次发布于 2025 年 1 月 3 日

fibronectin matrix

Nitric acid

HNO₃

Lime (citrus)

Viatris

India

Motric Bio

VIATRIS HEALTHCARE

France

Edwards Lifesciences Receives FDA Approval for TAVR Therapy in Asymptomatic Severe Aortic Stenosis

EPA Approves CRISPR-Based HLB-Resistant Citrus Rootstock to Combat Citrus Greening

Spectral Medical's Tigris Trial Nears Interim Enrollment Milestone for Septic Shock Therapy